End-stage kidney disease patients undergoing dialysis treatment
Conditions
Interventions
None listed
Sponsors
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Science, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing maintenance hemodialysis
Exclusion criteria
Exclusion criteria: Patients who do not agree informed consent. Patients who have hospitalization owing to cardiovascular disease, malignancy and infectious disease during 6 months. Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of serum uremic toxins level | — |
Secondary
| Measure | Time frame |
|---|---|
| Removal of uremic toxins with hemodialyzer | — |
Countries
Japan
Contacts
Public ContactSuguru Yamamoto
Niigata University Medical and Dental Hospital Division of Blood Purification Therapy
Outcome results
None listed